Cellebrite DI (NASDAQ:CLBT – Get Rating) and UiPath (NYSE:PATH – Get Rating) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, analyst recommendations and institutional ownership. Volatility and Risk Cellebrite DI has a beta of 1.18, […]